OpenHealth Technologies has announced it has raised $3 million in seed funding to build the central infrastructure for lab data, aiming to turn fragmented results into actionable health insights for millions of patients and organizations worldwide.
The funding round was led by YZR Capital and joined by GoHub Ventures, xdeck ventures, Edenbase, and Exceptional Ventures, with renewed support from existing investors Octopus Ventures and Calm/Storm Ventures. This latest round brings OpenHealth’s total funding to $4.3 million.
“Our mission is clear: we want to empower people and organizations to use health data better,” said Gerrit Glass, CEO and Founder of OpenHealth. “Most lab results today are fragmented, unstructured, and underutilized. We’re changing that by building the rails for a smarter, interoperable health ecosystem.”
Tackling Healthcare’s Biggest Data Blind Spot
Despite being the basis for more than 70% of clinical decisions, lab results remain one of healthcare’s most underutilized resources. OpenHealth highlights that 80% of health data is unstructured and untapped, costing healthcare systems billions and delaying accurate diagnoses.
The impact is staggering:
-
Up to 15% of diagnoses are delayed or incorrect, consuming nearly €290 billion annually in the EU alone.
-
One in three adults with chronic conditions like diabetes go undiagnosed.
-
Life-threatening diseases, including prostate cancer, are often detected too late.
-
For healthtech innovators, integrating lab data remains prohibitively complex and resource-heavy.
“We need to shift the paradigm in healthcare towards empowering patients to take ownership of their health,” said Oke Eleazu, NHS Trust Chair. “Bringing health data together in one place with personalized content will be key to healthcare’s future.”
The OpenHealth Solution
OpenHealth is tackling the challenge through two core products:
-
Lab API – a universal converter that harmonizes raw lab data from any source, including PDFs, into AI-ready, clinically contextualized data with longitudinal tracking.
-
Health Portal – an interactive hub for lab report visualization and document management, available as a white-label platform or embeddable component for partners.
The platform currently harmonizes over 3,500 biomarkers, applying deep medical reasoning to make results comparable across labs and over time. It is GDPR- and LGPD-compliant, scalable, and interoperable, designed to meet the growing demands of AI-driven healthcare.
Growing Global Trust
Since its founding, OpenHealth has earned the trust of leading health organizations worldwide. Its clients include Latin America’s largest diagnostics and hospital groups, Smart Fit (the region’s largest gym chain), European healthtech leader Aware, and an expanding network of longevity providers across Europe and the Americas.
What’s Next
With the new funding, OpenHealth plans to:
-
Accelerate European expansion while continuing to strengthen its presence in Latin America.
-
Empower labs, healthtech startups, insurers, and pharmaceutical companies to build AI-first healthcare products using structured lab data.
-
Advance its AI-driven technology to make lab results accessible to millions of patients worldwide.
“Their solution addresses a critical pain point in healthcare infrastructure,” said Pablo Perea, Partner at GoHub Ventures. “With the global push toward interoperability and patient-centred data, their timing and technology are spot on.”
OpenHealth’s long-term vision is to build the world’s largest structured biomarker database, designed to positively impact over 100 million lives.
